Back to feed
NDRAENDRA Life Sciences Inc.
CIK 0001681682 · no recent filings · 0 insider transactions
Buy volume
$0
0 buy transactions
Sell volume
$0
0 sell transactions
Net flow
+$0
Net buying
Total flow
$0
0 priced transactions
Disclosure radarcross-source convergence
Divergent3/5 sources
14/100
Recent disclosures · timeline
- 8-K1.015.017.018.019.013d ago
Entry into a material agreement
- Form 1443d ago
Proposed sale of 70,822 sh ($425.0K) · discretionary
- 8-K7.01
Price · NDRA
Live chart by TradingViewLive chart via TradingView. Insider trade price and date are from the underlying SEC filing. Not financial advice.
Material events · 8-K
NDRA corporate events · live SEC data- 1.015.017.018.019.01Material3d ago
Entry into a material agreement; Change in control of registrant
Form 8-K — items reported: 1.01 Entry into a material agreement; 5.01 Change in control of registrant; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits.
Item 1.01 · Entry into a material agreement +4 moreView 8-K on EDGAR ↗ - 7.01
Institutional holders · 13F
Q1 2026 vs Q4 2025 · live SEC data1 fund holds$58.6K reported valueNet accumulating(1 adding · 0 reducing)
| Fund | Shares | Value | % of portfolio | QoQ |
|---|---|---|---|---|
| Vanguard Group Inc | 12,937 | $58.6K | 0.0% | New |
Proposed sales · Form 144
selling intent · live SEC data1 notice$425.0K proposed to sell0/1 under a 10b5-1 plan
| Filed | Filer | Shares | Est. value | Approx. sale | Source of shares | Plan |
|---|---|---|---|---|---|---|
| 3d ago | Anthony DiGiandomenico Board Member | 70,822 | $425.0K | Jun 26, 2026 | Private Placement | Discretionary |
Recent insider transactions
No insider transactions recorded for NDRA.